human | Q5 |
P11496 | CiNii Research ID | 1070298510567815043 |
P9776 | e-Rad researcher number | 90512434 |
P7783 | J-GLOBAL ID | 201401012191966313 |
P496 | ORCID iD | 0000-0001-5806-1090 |
P5029 | Researchmap ID | 7000008687 |
P69 | educated at | Kumamoto University | Q1148782 |
Tokyo Medical and Dental University | Q3180921 | ||
P108 | employer | Kyoto University | Q336264 |
Nara Institute of Science and Technology | Q843253 | ||
P734 | family name | Okita | Q40102866 |
Okita | Q40102866 | ||
Okita | Q40102866 | ||
P735 | given name | Keisuke | Q6383879 |
Keisuke | Q6383879 | ||
P106 | occupation | researcher | Q1650915 |
Q29615748 | A more efficient method to generate integration-free human iPS cells |
Q37014144 | Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory |
Q34314350 | An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells |
Q45881050 | Artificial acceleration of mammalian cell reprogramming by bacterial proteins |
Q38791791 | Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates |
Q39856765 | Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells |
Q50651044 | Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate. |
Q64072311 | De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency |
Q34039005 | Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells |
Q42072961 | Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate |
Q39961521 | Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells |
Q36140488 | Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells |
Q42820289 | Drug screening for ALS using patient-specific induced pluripotent stem cells |
Q21135358 | ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the maintenance and induction of pluripotency |
Q30716660 | Endomucin is expressed in embryonic dorsal aorta and is able to inhibit cell adhesion. |
Q37734460 | Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects. |
Q38754538 | Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity |
Q36885838 | Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins |
Q33413336 | Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells |
Q35143768 | Generation and characterization of induced pluripotent stem cells from Aid-deficient mice |
Q28131699 | Generation of germline-competent induced pluripotent stem cells |
Q29614794 | Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts |
Q45013661 | Generation of mouse-induced pluripotent stem cells with plasmid vectors |
Q34750323 | Generation of pluripotent stem cells from adult mouse liver and stomach cells |
Q34017132 | Generation of retinal cells from mouse and human induced pluripotent stem cells |
Q54427794 | Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. |
Q73389629 | Genomic organization and characterization of the mouse ELYS gene |
Q38953434 | Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells |
Q21562159 | Gingival fibroblasts as a promising source of induced pluripotent stem cells |
Q49808462 | Human AK2 links intracellular bioenergetic redistribution to the fate of hematopoietic progenitors |
Q39481077 | Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors. |
Q48132718 | Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. |
Q52873719 | Hybrid Cellular Metabolism Coordinated by Zic3 and Esrrb Synergistically Enhances Induction of Naive Pluripotency. |
Q84487554 | Hypoxia enhances the generation of induced pluripotent stem cells |
Q28506055 | Identification of a novel transcription factor, ELYS, expressed predominantly in mouse foetal haematopoietic tissues |
Q48294409 | Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains. |
Q84949816 | Immunogenicity of induced pluripotent stem cells |
Q57454780 | Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development |
Q34090220 | Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice |
Q35088515 | Induced pluripotent stem cells: opportunities and challenges |
Q27437615 | Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A |
Q37737383 | Induction of pluripotency by defined factors |
Q48770547 | Induction of pluripotent stem cells from fibroblast cultures |
Q28646074 | Intracellular signaling pathways regulating pluripotency of embryonic stem cells |
Q35453993 | KLF4 N-terminal variance modulates induced reprogramming to pluripotency |
Q60083457 | Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells |
Q38635387 | MHC matching improves engraftment of iPSC-derived neurons in non-human primates |
Q34257813 | Methods for iPS cell generation for basic research and clinical applications. |
Q45736205 | Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness |
Q52889838 | Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs. |
Q39805226 | OVOL2 Maintains the Transcriptional Program of Human Corneal Epithelium by Suppressing Epithelial-to-Mesenchymal Transition. |
Q39831725 | Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors |
Q99248457 | Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors |
Q34404346 | Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation |
Q28591143 | Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein |
Q36448423 | Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells |
Q43909637 | Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". |
Q36007952 | Rewinding the process of mammalian extinction |
Q47707965 | Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts |
Q36059427 | Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency |
Q24645906 | Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation |
Q52719972 | Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs. |
Q29619160 | Suppression of induced pluripotent stem cell generation by the p53-p21 pathway |
Q92253393 | Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility |
Q51314632 | Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model. |
Q39821921 | Transplantation of mouse induced pluripotent stem cells into the cochlea |
Q34991636 | Variation in the safety of induced pluripotent stem cell lines |
Q41463591 | X-linked severe combined immunodeficiency (X-SCID) rats for xeno-transplantation and behavioral evaluation. |
Q37819946 | iPS cells for transplantation. |
Q42017884 | miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues |
Search more.